Introduction
Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance
. The aim of this study was to investigate the cellular pathways that are important to this process.
Materials and methods

Endothelial cell culture
Human umbilical cord endothelial cells (HUVEC) were isolated from umbilical cords as previously described [14] . HUVEC [14] . (Fig. 1B) . (Fig. 1C) (Fig. 3C, D) . Using confocal microscopy we could confirm the TSP-1 staining pattern around the nucleus and at the plasma membrane. Moreover, the surface of the apoptotic cell that is attached to the plasma membrane of the EC displays a strong TSP-1 signal (Fig. 3E, F) .
Induction of apoptosis in eEND2 cells
Apoptosis in eEND2 cells was induced by ultraviolet light (254 nm) as described previously for HMEC-1 cells
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Results
Binding of apoptotic cells enhances expression of TSP-1 in human ECs
Following our hypothesis that accumulation of apoptotic cells leads to the release of endothelial-derived chemokines and other soluble factors that facilitate phagocyte attraction as well as recognition and engulfment of apoptotic cells we examined changes in the expression of TSP-1 in human ECs
Next, we pre-incubated HUVEC with cytochalasin D (CytD) to prevent engulfment but not binding of apoptotic eEND2 cells. CytD is a toxin that rapidly inhibits the polymerization of microtubules. Pre-treatment with CytD for 30 min. did not result in significant changes in apoptotic cell-induced TSP-1 expression in HUVEC
Fig. 1 Apoptotic cells induce increased TSP-1 expression in ECs. (A) HUVEC or HMEC-1 cells were exposed to apoptotic eEND2 cells for 4 hrs and differences in the expression of TSP-1 transcript was measured by real-time qPCR (n ϭ 8). (B) HUVEC were exposed to apoptotic eEND2 cells for three and for 8 hrs and TSP-1 protein in the supernatant was measured by ELISA (n ϭ 4). (C) Pre-incubation with cytochalasin D did not prevent apoptotic-cell-induced increase in TSP-1 mRNA expression in HUVEC (n ϭ 3). Data are given as mean Ϯ S.D. (*P Ͻ 0.05 **P Ͻ 0.001).
Fig. 2 Apoptotic cell-induced expression of TSP-1 in HUVEC is mediated by the B-Raf/MEK/ERK pathway. (A) Exposure of HUVEC to apoptotic eEND2 cells led to a rapid activation of ERK1/2 (left) and B-Raf (right). Changes in phosphorylation were determined by calculation of the ratio of phosphorylated to unphosphorylated ERK1/2 or B-Raf protein, respectively (n ϭ 6). (B) Immunocytochemical
Conditioned supernatant of ECs induced macrophage activation
We recently showed that apoptotic cells have the potential to induce an inflammatory phenotype in human ECs [14] . (Fig. 5A) . [1, [15] [16] [17] [19, 20] [30, 31] . In fact, TSP-1 expression is rapidly increased at sites of tissue inflammation or injury and TSP-1 null mice display persistent multi-organ inflammation [32] [33] [34] [35] . Furthermore, TSP-1 has been shown to play a role in attracting macrophages to the site of inflammation or injury [18, 36] 
To answer the question whether this effect has any impact on macrophage activation we measured different cytokine and chemokine transcript profiles in human primary monocytederived macrophages and U937 cells. In primary macrophages cS/N of HUVEC induced a 4-to 10-fold increase in transcript amount of IL-1␤, TNF-␣ and IL-8 after 3 hrs compared to supernatant of unstimulated cells whereas expression of MCP-1 and IL-10 was reduced after stimulation with cS/N. M-CSF obviously had no effect on expression of the pro-inflammatory markers and IL-10 whereas MCP-1 transcript amount was slightly increased (Fig. 4A). U937 cells exposed to conditioned supernatant respond with slight increases in IL-8 and TNF-␣ expression and a reduction in IL-10 transcript amount (Fig. 4B). Taken together, these results suggest that cS/N of HUVEC exposed to apoptotic ECs led to an activation of primary human monocytes and, to a lesser extent, of U937 cells.
Endothelial TSP-1 enhances recognition and binding of apoptotic cells by macrophages
We next examined whether HUVEC-derived TSP-1 facilitates clearance of apoptotic mouse eEND2 cells. In a first set of experiments we neutralized secreted TSP-1 with an inhibitory antibody or blocked ␣V␤3 integrin or CD36 on the surface of HUVEC and measured changes in the binding or uptake of apoptotic eEND2 cells after 1 and 6 hrs. Surprisingly, pre-incubation of HUVEC with the RGD peptide or an anti-CD36 antibody as well as neutralizing TSP-1 in the cS/N did not result in any changes in apoptotic cell engulfment or even cell binding. We repeated these experiments with both ␣V␤3 integrin and CD36 being blocked by a mix of antibodies and RGD peptides before apoptotic cells were added. Additionally, TSP-1 in the cS/N was neutralized by an inhibitory anti-TSP-1 antibody. Even under these conditions binding of apoptotic eEND2 cells to HUVEC was not significantly altered
We then tested whether HUVEC-derived TSP-1 augmented engulfment of apoptotic cells by monocyte-derived macrophages or by PMA-treated U937 cells (Fig. 5B). Preincubation of apoptotic eEND2 cells with cS/N of HUVEC increased the phagocytic index of monocyte-derived macrophages from 48.6 Ϯ 12.4 (supernatant of untreated HUVEC) to 151 Ϯ 21.32 (cS/N). This increase in engulfment
Discussion
Autoimmune diseases like AAV or SLE as well as other diseases with vascular involvement are characterized by high numbers of detached inflammatory ECs in the circulation
Our findings provide new insights into the as yet poorly understood interactions between circulating inflammatory ECs and the vascular endothelium. Apoptosis and the subsequent removal of dying cells are natural occurring processes and of vital importance for maintaining homeostasis and integrity of the organism. Under normal circumstances one of the hallmarks of apoptotic cell clearance is the prevention of pro-inflammatory signalling and the absence of immune responses
